Hawk Ridge Capital Management - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 186 filers reported holding ANI PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
Hawk Ridge Capital Management ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$8,012,000
-31.2%
196,661
+4.2%
1.35%
-28.8%
Q4 2019$11,641,000
+3.1%
188,761
+21.8%
1.89%
-16.4%
Q3 2019$11,294,000
+11.2%
154,961
+25.4%
2.26%
+20.2%
Q2 2019$10,157,000
+16.5%
123,5610.0%1.88%
+2.5%
Q1 2019$8,716,000123,5611.84%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
FIRST WILSHIRE SECURITIES MANAGEMENT INC 328,494$15,137,0004.72%
TANG CAPITAL MANAGEMENT LLC 300,000$13,824,0002.78%
Mesirow Financial Investment Management, Inc. 12,277$566,0001.63%
Parkman Healthcare Partners LLC 137,226$6,323,0001.40%
Global Alpha Capital Management Ltd. 284,831$13,125,0001.27%
Stonepine Capital Management, LLC 52,290$2,410,0001.11%
1492 Capital Management LLC 43,611$2,010,0000.99%
MARATHON CAPITAL MANAGEMENT 74,770$3,445,0000.81%
Walthausen & Co., LLC 61,456$2,832,0000.74%
Rubric Capital Management LP 307,557$14,172,0000.67%
View complete list of ANI PHARMACEUTICALS INC shareholders